Genotype and phenotype analysis of patients with pediatric cutaneous mastocytosis, especially wild-type KIT patients

Noriko Arase1, Mari Wataya-Kaneda1, Hiroyuki Murota1,2

  • 1Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Japan.

The Journal of Dermatology
|February 21, 2020
PubMed

Insights

Pediatric cutaneous mastocytosis (CM) in Japanese patients shows similar KIT mutation frequencies to European cohorts. Clinical phenotypes, including macule distribution, did not significantly differ between patients with and without KIT mutations.

Area of Science:

  • Dermatology
  • Genetics
  • Pediatrics

Background:

  • Pediatric cutaneous mastocytosis (CM) is often linked to KIT gene mutations in mast cells.
  • However, some CM patients lack KIT mutations, indicating other underlying mechanisms.
  • The relationship between KIT mutation status and clinical presentation in pediatric CM, particularly in wild-type KIT cases, remains unclear.

Purpose of the Study:

  • To investigate the presence of KIT mutations in Japanese pediatric CM patients.
  • To analyze the association between KIT mutation status and clinical phenotypes in this cohort.
  • To compare findings with existing European studies.

Main Methods:

  • Genetic analysis of the KIT gene in skin mast cells from 11 Japanese pediatric CM patients.
  • Observation and documentation of clinical phenotypes, including macule distribution.

Main Results:

  • The frequency of KIT mutations and wild-type KIT in the Japanese cohort was comparable to European findings.
  • No significant differences in the distribution of overall macules were observed between patients with and without KIT mutations.

Conclusions:

  • KIT mutation status in pediatric CM may not strongly influence the observed clinical phenotype, such as macule distribution.
  • Further research is needed to understand the genetic landscape and clinical correlations in pediatric CM, especially in wild-type KIT cases.